Intrinsic Optical Imaging Study to Map Neocortical Seizure in Human Epilepsy Patients
NCT ID: NCT00195052
Last Updated: 2025-06-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
34 participants
OBSERVATIONAL
2002-05-31
2025-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electroencephalography (EEG) and Deep Brain Stimulation (DBS) in Epilepsy
NCT00194870
Human Intracranial Electrophysiology
NCT05529264
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
NCT02107989
Optimization of Human Cortical Stimulation
NCT01198964
Monitoring Patients With Uncontrolled Epilepsy
NCT00001149
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Epilepsy Patients
Intrinsic signal imaging of human cortex
Light is shined on the brain at 540 nm and 610 nm and images are acquired at 10 frames per second.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intrinsic signal imaging of human cortex
Light is shined on the brain at 540 nm and 610 nm and images are acquired at 10 frames per second.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects undergoing neurosurgical operations requiring cortical mapping
Exclusion Criteria
6 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Weill Medical College of Cornell University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Theodore H Schwartz, MD
Role: PRINCIPAL_INVESTIGATOR
Weill Cornell Medical College/New York Presbyterian Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Weill Cornell Medical College/New York Presbyterian Hospital
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0102004808
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.